MRNA Looks ready to roll overMRNA has gone on an absurd run, and the technical setup looks ripe to the short side. It's all over WSB, looks ripe for a slaughter. There is upside risk with a possible FDA approval so trades have to factor that in. Shortby WLinvestmentUpdated 7711